Vildagliptin / Metformin hydrochloride Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

Sitagliptin / Metformin hydrochloride Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Cardalis Europeiska unionen - svenska - EMA (European Medicines Agency)

cardalis

ceva santé animale - benazepril hydrochloride, spironolactone - hjÄrt-kÄrlsystemet - hundar - för behandling av kronisk hjärtsvikt orsakad av kronisk degenerativ ventrikulär sjukdom hos hundar (med lämpligt diuretiskt stöd).

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Europeiska unionen - svenska - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

Pevisone 1 mg/g + 10 mg/g Kräm Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pevisone 1 mg/g + 10 mg/g kräm

karo pharma ab - ekonazolnitrat; triamcinolonacetonid - kräm - 1 mg/g + 10 mg/g - butylhydroxianisol hjälpämne; triamcinolonacetonid 1 mg aktiv substans; ekonazolnitrat 10 mg aktiv substans; bensoesyra hjälpämne - kombinationer

Pevisone 1 mg/g + 10 mg/g Kräm Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pevisone 1 mg/g + 10 mg/g kräm

orifarm ab - ekonazolnitrat; triamcinolonacetonid - kräm - 1 mg/g + 10 mg/g - triamcinolonacetonid 1,1 mg aktiv substans; ekonazolnitrat 10 mg aktiv substans; bensoesyra hjälpämne; butylhydroxianisol hjälpämne - kombinationer

Pevisone 1 mg/g + 10 mg/g Kräm Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pevisone 1 mg/g + 10 mg/g kräm

paranova läkemedel ab - ekonazolnitrat; triamcinolonacetonid - kräm - 1 mg/g + 10 mg/g - ekonazolnitrat 10 mg aktiv substans; butylhydroxianisol hjälpämne; bensoesyra hjälpämne; triamcinolonacetonid 1 mg aktiv substans - kombinationer

Pevisone 1 mg/g + 10 mg/g Kräm Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pevisone 1 mg/g + 10 mg/g kräm

orifarm ab - ekonazolnitrat; triamcinolonacetonid - kräm - 1 mg/g + 10 mg/g - butylhydroxianisol hjälpämne; bensoesyra hjälpämne; ekonazolnitrat 10 mg aktiv substans; triamcinolonacetonid 1 mg aktiv substans - kombinationer

Pevisone 1 mg/g + 10 mg/g Kräm Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pevisone 1 mg/g + 10 mg/g kräm

orifarm ab - ekonazolnitrat; triamcinolonacetonid - kräm - 1 mg/g + 10 mg/g - butylhydroxianisol hjälpämne; bensoesyra hjälpämne; triamcinolonacetonid 1 mg aktiv substans; ekonazolnitrat 10 mg aktiv substans - kombinationer

Pevisone 1 mg/g + 10 mg/g Kräm Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pevisone 1 mg/g + 10 mg/g kräm

2care4 aps - ekonazolnitrat; triamcinolonacetonid - kräm - 1 mg/g + 10 mg/g - bensoesyra hjälpämne; butylhydroxianisol hjälpämne; ekonazolnitrat 10 mg aktiv substans; triamcinolonacetonid 1 mg aktiv substans - kombinationer